Influence of CYP2C9 and VKORC1 1173C/T Genotype on the Risk of Hemorrhagic Complications in African-American and European-American Patients on Warfarin
Authors:
- 25 July 2007
- journal article
- clinical trial
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 83 (2) , 312-321
Abstract
The association of CYP2C9 and VKORC1 1173C/T genotype and risk of hemorrhage among African Americans and European Americans is presented. This association was evaluated using Cox proportional hazard ...Keywords
This publication has 50 references indexed in Scilit:
- Translating the Results of Randomized Trials into Clinical PracticeStroke, 2006
- Heart Disease and Stroke Statistics—2006 UpdateCirculation, 2006
- Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarinThrombosis and Haemostasis, 2006
- A C1173T Dimorphism in the VKORC1 Gene Determines Coumarin Sensitivity and Bleeding RiskPLOS Medicine, 2005
- Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin DoseNew England Journal of Medicine, 2005
- Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarinThrombosis and Haemostasis, 2005
- Warfarin dosing and cytochrome P450 2C9 polymorphismsThrombosis and Haemostasis, 2004
- Complications of Oral Anticoagulant Therapy: Bleeding and Nonbleeding, Rates and Risk FactorsSeminars in Vascular Medicine, 2003
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complicationsThe Lancet, 1999
- Vitamin K1 (Phylloquinone) Content of Foods: A Provisional TableJournal of Food Composition and Analysis, 1993